{
  "response": {
    "status": 200
  },
  "symbol": {
    "id": 12802,
    "symbol": "NVCR",
    "title": "NovoCure",
    "aliases": [],
    "is_following": false,
    "watchlist_count": 5420
  },
  "cursor": {
    "more": true,
    "since": 255937588,
    "max": 255737741
  },
  "messages": [
    {
      "id": 255937588,
      "body": "$NVCR Tee&#39;ing up off 10 wk SMA. On the $100 roll to 2",
      "created_at": "2020-11-11T17:02:56Z",
      "user": {
        "id": 748375,
        "username": "FlynancialAnalyst",
        "name": "Logan McNulty",
        "avatar_url": "https://avatars.stocktwits.com/production/748375/thumb-1571430750.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/748375/thumb-1571430750.png",
        "join_date": "2016-05-09",
        "official": false,
        "identity": "User",
        "classification": [
          "suggested"
        ],
        "followers": 7014,
        "following": 230,
        "ideas": 38136,
        "watchlist_stocks_count": 18,
        "like_count": 38728,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5420
        }
      ],
      "likes": {
        "total": 1,
        "user_ids": [
          2133920
        ]
      },
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_255937588.png",
          "large": "https://charts.stocktwits.com/production/large_255937588.png",
          "original": "https://charts.stocktwits.com/production/original_255937588.png",
          "url": "https://charts.stocktwits.com/production/original_255937588.png"
        },
        "sentiment": {
          "basic": "Bullish"
        }
      }
    },
    {
      "id": 255926315,
      "body": "$NVCR @Chazdaq phone free walk kind of morning or something?",
      "created_at": "2020-11-11T16:28:16Z",
      "user": {
        "id": 707246,
        "username": "CCmoney7",
        "name": "C Marcus",
        "avatar_url": "http://avatars.stocktwits.com/images/default_avatar_thumb.jpg",
        "avatar_url_ssl": "https://s3.amazonaws.com/st-avatars/images/default_avatar_thumb.jpg",
        "join_date": "2016-03-15",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 17,
        "following": 68,
        "ideas": 4168,
        "watchlist_stocks_count": 89,
        "like_count": 1016,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1149,
        "title": "StockTwits for iOS",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5420
        }
      ],
      "conversation": {
        "parent_message_id": 255926315,
        "in_reply_to_message_id": null,
        "parent": true,
        "replies": 2
      },
      "likes": {
        "total": 2,
        "user_ids": [
          1419594,
          623810
        ]
      },
      "mentioned_users": [
        "@Chazdaq"
      ],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255907350,
      "body": "$NVCR $ZLAB Zai is catching up we better do something big at R&amp;D day",
      "created_at": "2020-11-11T15:33:08Z",
      "user": {
        "id": 1559609,
        "username": "blackjack17",
        "name": "Blackjack Capital",
        "avatar_url": "https://avatars.stocktwits.com/production/1559609/thumb-1535587923.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1559609/thumb-1535587923.png",
        "join_date": "2018-07-28",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 51,
        "following": 48,
        "ideas": 5939,
        "watchlist_stocks_count": 69,
        "like_count": 3078,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1149,
        "title": "StockTwits for iOS",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5420
        },
        {
          "id": 13944,
          "symbol": "ZLAB",
          "title": "Zai Lab Ltd",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 544
        }
      ],
      "conversation": {
        "parent_message_id": 255907350,
        "in_reply_to_message_id": null,
        "parent": true,
        "replies": 1
      },
      "likes": {
        "total": 4,
        "user_ids": [
          2133920,
          707246,
          1798946,
          1604062
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": {
          "basic": "Bullish"
        }
      }
    },
    {
      "id": 255905911,
      "body": "$NVCR Simmering pot...feels like the calm before the........",
      "created_at": "2020-11-11T15:29:29Z",
      "user": {
        "id": 623810,
        "username": "tdorsey",
        "name": "Tom Dorsey",
        "avatar_url": "https://avatars.stocktwits.com/production/623810/thumb-1450378629.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/623810/thumb-1450378629.png",
        "join_date": "2015-10-29",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 233,
        "following": 37,
        "ideas": 9063,
        "watchlist_stocks_count": 15,
        "like_count": 2688,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5420
        }
      ],
      "conversation": {
        "parent_message_id": 255905911,
        "in_reply_to_message_id": null,
        "parent": true,
        "replies": 6
      },
      "likes": {
        "total": 3,
        "user_ids": [
          2133920,
          1419594,
          1604062
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255905135,
      "body": "$NVCR added 20 dec 110 calls at $15.20. Ready to be wowed tomorrow",
      "created_at": "2020-11-11T15:27:26Z",
      "user": {
        "id": 707246,
        "username": "CCmoney7",
        "name": "C Marcus",
        "avatar_url": "http://avatars.stocktwits.com/images/default_avatar_thumb.jpg",
        "avatar_url_ssl": "https://s3.amazonaws.com/st-avatars/images/default_avatar_thumb.jpg",
        "join_date": "2016-03-15",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 17,
        "following": 68,
        "ideas": 4167,
        "watchlist_stocks_count": 89,
        "like_count": 1016,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1149,
        "title": "StockTwits for iOS",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5420
        }
      ],
      "conversation": {
        "parent_message_id": 255905135,
        "in_reply_to_message_id": null,
        "parent": true,
        "replies": 5
      },
      "likes": {
        "total": 5,
        "user_ids": [
          623810,
          2133920,
          1419594,
          1604062,
          1396153
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255904940,
      "body": "$NVCR new HOD",
      "created_at": "2020-11-11T15:26:57Z",
      "user": {
        "id": 2133920,
        "username": "SodApOp_PIMPski",
        "name": "Mike D",
        "avatar_url": "https://avatars.stocktwits.com/production/2133920/thumb-1597291570.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/2133920/thumb-1597291570.png",
        "join_date": "2019-06-11",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 80,
        "following": 33,
        "ideas": 10899,
        "watchlist_stocks_count": 53,
        "like_count": 8872,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2095,
        "title": "StockTwits For Android ",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": {
          "basic": "Bullish"
        }
      }
    },
    {
      "id": 255885136,
      "body": "$NVCR back to $140 we go!",
      "created_at": "2020-11-11T14:40:52Z",
      "user": {
        "id": 4263524,
        "username": "Vkallday",
        "name": "Vitaliy K",
        "avatar_url": "http://avatars.stocktwits.com/images/default_avatar_thumb.jpg",
        "avatar_url_ssl": "https://s3.amazonaws.com/st-avatars/images/default_avatar_thumb.jpg",
        "join_date": "2020-11-03",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 0,
        "following": 0,
        "ideas": 5,
        "watchlist_stocks_count": 0,
        "like_count": 7,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "likes": {
        "total": 1,
        "user_ids": [
          1419594
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255877520,
      "body": "$NVCR $ZLAB Dream Team",
      "created_at": "2020-11-11T14:18:32Z",
      "user": {
        "id": 1559609,
        "username": "blackjack17",
        "name": "Blackjack Capital",
        "avatar_url": "https://avatars.stocktwits.com/production/1559609/thumb-1535587923.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1559609/thumb-1535587923.png",
        "join_date": "2018-07-28",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 50,
        "following": 48,
        "ideas": 5935,
        "watchlist_stocks_count": 69,
        "like_count": 3077,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1149,
        "title": "StockTwits for iOS",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5420
        },
        {
          "id": 13944,
          "symbol": "ZLAB",
          "title": "Zai Lab Ltd",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 542
        }
      ],
      "likes": {
        "total": 8,
        "user_ids": [
          1798946,
          1531906,
          1304262,
          623810,
          1271837,
          2133920,
          1241988,
          1604062
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": {
          "basic": "Bullish"
        }
      }
    },
    {
      "id": 255876911,
      "body": "$NVCR Great day for Novocure and partner $ZLAB as well!",
      "created_at": "2020-11-11T14:16:34Z",
      "user": {
        "id": 1798946,
        "username": "DoctorInvestor45",
        "name": "Phil",
        "avatar_url": "https://avatars.stocktwits.com/production/1798946/thumb-1547010029.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1798946/thumb-1547010029.png",
        "join_date": "2019-01-08",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 130,
        "following": 8,
        "ideas": 1529,
        "watchlist_stocks_count": 53,
        "like_count": 1177,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1149,
        "title": "StockTwits for iOS",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5420
        },
        {
          "id": 13944,
          "symbol": "ZLAB",
          "title": "Zai Lab Ltd",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 544
        }
      ],
      "likes": {
        "total": 6,
        "user_ids": [
          1559609,
          1304262,
          623810,
          2133920,
          4263524,
          1518510
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": {
          "basic": "Bullish"
        }
      }
    },
    {
      "id": 255876755,
      "body": "$NVCR Congratulations, longs! Wonderful news!",
      "created_at": "2020-11-11T14:15:59Z",
      "user": {
        "id": 744798,
        "username": "datajunky",
        "name": "datajunky",
        "avatar_url": "https://avatars.stocktwits.com/production/744798/thumb-1599067718.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/744798/thumb-1599067718.png",
        "join_date": "2016-05-04",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 23,
        "following": 83,
        "ideas": 514,
        "watchlist_stocks_count": 83,
        "like_count": 2271,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2095,
        "title": "StockTwits For Android ",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "likes": {
        "total": 1,
        "user_ids": [
          1531906
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255875346,
      "body": "$NVCR Wow fabulous news. Big day ahead and conference tomorrow where they will be unveiling new data. $140 coming",
      "created_at": "2020-11-11T14:11:01Z",
      "user": {
        "id": 4266751,
        "username": "zakmo",
        "name": "Mohammed Zakir",
        "avatar_url": "http://avatars.stocktwits.com/images/default_avatar_thumb.jpg",
        "avatar_url_ssl": "https://s3.amazonaws.com/st-avatars/images/default_avatar_thumb.jpg",
        "join_date": "2020-11-03",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 0,
        "following": 0,
        "ideas": 6,
        "watchlist_stocks_count": 1,
        "like_count": 16,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2095,
        "title": "StockTwits For Android ",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "likes": {
        "total": 2,
        "user_ids": [
          1798946,
          1531906
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": {
          "basic": "Bullish"
        }
      }
    },
    {
      "id": 255872066,
      "body": "Novocure $NVCR announced that it has received the CE Mark for the NovoTTF-100L system from the Notified Body. The application of the CE mark enables Novocure to commercialize the device as a first-line treatment in combination with pemetrexed and platinum-based chemotherapy...",
      "created_at": "2020-11-11T13:59:31Z",
      "user": {
        "id": 977068,
        "username": "InvestorsObserver",
        "name": "InvestorsObserver",
        "avatar_url": "https://avatars.stocktwits.com/production/977068/thumb-1579620603.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/977068/thumb-1579620603.png",
        "join_date": "2017-03-01",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 328,
        "following": 4,
        "ideas": 4905,
        "watchlist_stocks_count": 0,
        "like_count": 2,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255870245,
      "body": "$NVCR Novocure&#39;s non-invasive cancer device Ok&#39;d in Europe for mesothelioma \n\nhttps://newsfilter.io/a/149ac0d88874baa80a993b0ea8de1447",
      "created_at": "2020-11-11T13:52:23Z",
      "user": {
        "id": 2762379,
        "username": "Newsfilter",
        "name": "@newsfilterio",
        "avatar_url": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "join_date": "2019-09-01",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 7620,
        "following": 16,
        "ideas": 622260,
        "watchlist_stocks_count": 1,
        "like_count": 531,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "links": [
        {
          "title": "Novocure's non-invasive cancer device Ok'd in Europe for mesothelioma",
          "url": "https://newsfilter.io/a/149ac0d88874baa80a993b0ea8de1447",
          "shortened_url": "https://newsfilter.io/a/149ac0d88874baa80a993b0ea8de1447",
          "shortened_expanded_url": "newsfilter.io/a/149ac0d8887...",
          "description": "Novocure has received the CE Mark for the NovoTTF-100L system, for the commercialization of the device as a first-line treatment in combination with Eli Lilly's Alimta and platinum-based chemotherapy for malignant pleural mesothelioma, in the European Union and Switzerland.The FDA approved the NovoTTF-100L System for MPM in May 2019 under the Humanitarian Device Exemption pathway.NovoTTF-100L is a noninvasive, antimitotic cancer treatment for MPM, and delivers Tumor Treating Fields using electric fields to disrupt cell division.",
          "image": "https://newsfilter.io/meta-images/?url=https://storage.googleapis.com/iex/api/logos/NVCR.png",
          "created_at": "2020-11-11T13:52:24Z",
          "video_url": null,
          "source": {
            "name": "Newsfilter",
            "website": "https://newsfilter.io"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255868337,
      "body": "$NVCR \ud83d\udd25",
      "created_at": "2020-11-11T13:43:41Z",
      "user": {
        "id": 1604062,
        "username": "SMDMNM",
        "name": "Matt",
        "avatar_url": "https://avatars.stocktwits.com/production/1604062/thumb-1601940480.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1604062/thumb-1601940480.png",
        "join_date": "2018-09-09",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 26,
        "following": 41,
        "ideas": 1946,
        "watchlist_stocks_count": 12,
        "like_count": 3632,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1149,
        "title": "StockTwits for iOS",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "likes": {
        "total": 2,
        "user_ids": [
          1531906,
          2133920
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255864590,
      "body": "$NVCR another building block",
      "created_at": "2020-11-11T13:27:00Z",
      "user": {
        "id": 1518510,
        "username": "traderjoze",
        "name": "TJ",
        "avatar_url": "https://avatars.stocktwits.com/production/1518510/thumb-1567694088.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1518510/thumb-1567694088.png",
        "join_date": "2018-06-12",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 100,
        "following": 13,
        "ideas": 15930,
        "watchlist_stocks_count": 41,
        "like_count": 2078,
        "plus_tier": "year",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1149,
        "title": "StockTwits for iOS",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "likes": {
        "total": 3,
        "user_ids": [
          4263524,
          1604062,
          4266751
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": {
          "basic": "Bullish"
        }
      }
    },
    {
      "id": 255859952,
      "body": "$NVCR Novocure Receives CE Mark for NovoTTF-100L\u2122 System https://www.otcdynamics.com/nvcr-novocure-receives-ce-mark-for-novottf-100l-system",
      "created_at": "2020-11-11T13:04:13Z",
      "user": {
        "id": 253206,
        "username": "otcdynamics",
        "name": "otcdynamics",
        "avatar_url": "https://avatars.stocktwits.com/production/253206/thumb-1432182723.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/253206/thumb-1432182723.png",
        "join_date": "2013-08-16",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 407,
        "following": 0,
        "ideas": 59227,
        "watchlist_stocks_count": 0,
        "like_count": 55,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5512,
        "title": "project_n",
        "url": "https://www.otcdynamics.com"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "links": [
        {
          "title": "$NVCR Novocure Receives CE Mark for NovoTTF-100L\u2122 System",
          "url": "https://www.otcdynamics.com/nvcr-novocure-receives-ce-mark-for-novottf-100l-system",
          "shortened_url": "https://www.otcdynamics.com/nvcr-novocure-receives-ce-mark-for-novottf-100l-system",
          "shortened_expanded_url": "otcdynamics.com/nvcr-novocu...",
          "description": "Novocure (NASDAQ: NVCR), a global oncology company working to extend survival in some of the most aggressive forms of cancer, today announced that it has received the CE Mark for the NovoTTF-100L system from the Notified Body (T\u00dcV).",
          "image": null,
          "created_at": "2020-11-11T13:04:14Z",
          "video_url": null,
          "source": {
            "name": "Otcdynamics",
            "website": "https://www.otcdynamics.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255857913,
      "body": "$NVCR welcome to Europe \ud83d\udc4d",
      "created_at": "2020-11-11T12:52:59Z",
      "user": {
        "id": 2133920,
        "username": "SodApOp_PIMPski",
        "name": "Mike D",
        "avatar_url": "https://avatars.stocktwits.com/production/2133920/thumb-1597291570.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/2133920/thumb-1597291570.png",
        "join_date": "2019-06-11",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 80,
        "following": 33,
        "ideas": 10904,
        "watchlist_stocks_count": 53,
        "like_count": 8876,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2095,
        "title": "StockTwits For Android ",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5420
        }
      ],
      "conversation": {
        "parent_message_id": 255857913,
        "in_reply_to_message_id": null,
        "parent": true,
        "replies": 1
      },
      "likes": {
        "total": 7,
        "user_ids": [
          1798946,
          282175,
          473304,
          1604062,
          3281228,
          246797,
          4266751
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255857055,
      "body": "Novocure Receives CE Mark For NovoTTF-100L System\n\nRelated Tickers: $NVCR",
      "created_at": "2020-11-11T12:47:09Z",
      "user": {
        "id": 3539670,
        "username": "QuantData",
        "name": "Quant Data",
        "avatar_url": "https://avatars.stocktwits.com/production/3539670/thumb-1602473985.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/3539670/thumb-1602473985.png",
        "join_date": "2020-06-03",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 788,
        "following": 0,
        "ideas": 12838,
        "watchlist_stocks_count": 0,
        "like_count": 20,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5828,
        "title": "QuantData",
        "url": "https://quantdata.us"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "likes": {
        "total": 1,
        "user_ids": [
          4266751
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255855261,
      "body": "$NVCR [15s. delayed]: Issued Press Release on November 11, 07:30:00: Novocure Receives CE Mark for NovoTTF-100L\u2122 System https://s.flashalert.me/kV95LW",
      "created_at": "2020-11-11T12:35:31Z",
      "user": {
        "id": 595702,
        "username": "fla",
        "name": "FlashAlert_me",
        "avatar_url": "https://avatars.stocktwits.com/production/595702/thumb-1550769466.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/595702/thumb-1550769466.png",
        "join_date": "2015-09-09",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 2690,
        "following": 60,
        "ideas": 735256,
        "watchlist_stocks_count": 0,
        "like_count": 4,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 4622,
        "title": "FlashAlert",
        "url": "https://flashalert.me/"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "links": [
        {
          "title": "Flash Alert",
          "url": "https://s.flashalert.me/kV95LW",
          "shortened_url": "https://s.flashalert.me/kV95LW",
          "shortened_expanded_url": "businesswire.com/news/home/...",
          "description": "Real-time alerts about equities, ETFs, cryptocurrencies and more sent to any device",
          "image": null,
          "created_at": "2020-11-11T12:35:31Z",
          "video_url": null,
          "source": {
            "name": "Flashalert",
            "website": "https://flashalert.me"
          }
        }
      ],
      "likes": {
        "total": 1,
        "user_ids": [
          1798946
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255854575,
      "body": "$NVCR Novocure Receives CE Mark for NovoTTF-100L\u2122 System\nhttps://www.stocktitan.net/news/NVCR/novocure-receives-ce-mark-for-novo-ttf-100l-88wemvv71nio.html",
      "created_at": "2020-11-11T12:31:28Z",
      "user": {
        "id": 3372441,
        "username": "Stock_Titan",
        "name": "StockTitan",
        "avatar_url": "https://avatars.stocktwits.com/production/3372441/thumb-1588173612.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/3372441/thumb-1588173612.png",
        "join_date": "2020-04-28",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 474,
        "following": 0,
        "ideas": 32073,
        "watchlist_stocks_count": 0,
        "like_count": 0,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5677,
        "title": "StockTitan",
        "url": "https://stocktitan.net"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "links": [
        {
          "title": "Novocure Receives CE Mark for NovoTTF-100L(TM) System | StockTitan.net",
          "url": "https://www.stocktitan.net/news/NVCR/novocure-receives-ce-mark-for-novo-ttf-100l-88wemvv71nio.html",
          "shortened_url": "https://www.stocktitan.net/news/NVCR/novocure-receives-ce-mark-for-novo-ttf-100l-88wemvv71nio.html",
          "shortened_expanded_url": "stocktitan.net/news/NVCR/no...",
          "description": "ST. HELIER, Jersey--()--Novocure (NASDAQ: NVCR), a global oncology company working to extend survival in some of the most aggressive forms of cancer, today announced that it has received the CE Mark for the NovoTTF-100L system from the Notified Body (TUV).",
          "image": "https://static.stocktitan.net/company-logo/nvcr.png",
          "created_at": "2020-11-11T12:31:30Z",
          "video_url": null,
          "source": {
            "name": "Stocktitan",
            "website": "https://www.stocktitan.net"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255854504,
      "body": "$NVCR Novocure Receives CE Mark for NovoTTF-100L\u2122 System \n\nhttps://newsfilter.io/a/7ee9f7791a159843ac57414f4ed6ebe1",
      "created_at": "2020-11-11T12:31:03Z",
      "user": {
        "id": 2762379,
        "username": "Newsfilter",
        "name": "@newsfilterio",
        "avatar_url": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "join_date": "2019-09-01",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 7620,
        "following": 16,
        "ideas": 621988,
        "watchlist_stocks_count": 1,
        "like_count": 531,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "links": [
        {
          "title": "Novocure Receives CE Mark for NovoTTF-100L\u2122 System",
          "url": "https://newsfilter.io/a/7ee9f7791a159843ac57414f4ed6ebe1",
          "shortened_url": "https://newsfilter.io/a/7ee9f7791a159843ac57414f4ed6ebe1",
          "shortened_expanded_url": "newsfilter.io/a/7ee9f7791a1...",
          "description": "Novocure announced that it has received the CE Mark for the NovoTTF-100L system from the Notified Body. The application of the CE mark enables Novocure to commercialize the device as a first-line treatment in combination with pemetrexed and platinum-based chemotherapy for unresectable, locally advanced or metastatic, malignant pleural mesothelioma in the European Union and Switzerland.",
          "image": "https://newsfilter.io/meta-images/?url=https://storage.googleapis.com/iex/api/logos/NVCR.png",
          "created_at": "2020-11-11T12:31:04Z",
          "video_url": null,
          "source": {
            "name": "Newsfilter",
            "website": "https://newsfilter.io"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255852057,
      "body": "$NVCR 150M revolving credit facility from Chase and my understanding could go to a quarter Billion facility. Is that in addition to the 575Mil? This is all in anticipation of the readouts but what do you think this money will be needed for come readouts?",
      "created_at": "2020-11-11T12:12:54Z",
      "user": {
        "id": 3137019,
        "username": "DoctorCurious",
        "name": "DoctorCurious",
        "avatar_url": "http://avatars.stocktwits.com/images/default_avatar_thumb.jpg",
        "avatar_url_ssl": "https://s3.amazonaws.com/st-avatars/images/default_avatar_thumb.jpg",
        "join_date": "2020-02-29",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 2,
        "following": 0,
        "ideas": 100,
        "watchlist_stocks_count": 32,
        "like_count": 40,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "conversation": {
        "parent_message_id": 255852057,
        "in_reply_to_message_id": null,
        "parent": true,
        "replies": 1
      },
      "likes": {
        "total": 1,
        "user_ids": [
          4266751
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": {
          "basic": "Bullish"
        }
      }
    },
    {
      "id": 255835974,
      "body": "$GBT MMs I told you from day one.  Find the buyers and sell the company.  Learn from Dr. Hung at $NVCR did with Medieval and now with nvcr did.  htf you let good company and good drug sp dropped to a 52 week low?",
      "created_at": "2020-11-11T07:43:35Z",
      "user": {
        "id": 54489,
        "username": "Secret_Stocks",
        "name": "J J",
        "avatar_url": "https://avatars.stocktwits.com/production/54489/thumb-1397441912.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/54489/thumb-1397441912.png",
        "join_date": "2011-02-23",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 667,
        "following": 101,
        "ideas": 12542,
        "watchlist_stocks_count": 165,
        "like_count": 493,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1149,
        "title": "StockTwits for iOS",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 12761,
          "symbol": "GBT",
          "title": "Global Blood Therapeutics",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 4726
        },
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "likes": {
        "total": 2,
        "user_ids": [
          3094956,
          4266751
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255825164,
      "body": "$NVCR https://www.fiercepharma.com/marketing/merck-scraps-keytruda-lung-cancer-trial-adding-bristol-myers-yervoy-what-about-opdivo",
      "created_at": "2020-11-11T04:29:59Z",
      "user": {
        "id": 1518510,
        "username": "traderjoze",
        "name": "TJ",
        "avatar_url": "https://avatars.stocktwits.com/production/1518510/thumb-1567694088.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1518510/thumb-1567694088.png",
        "join_date": "2018-06-12",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 101,
        "following": 13,
        "ideas": 15929,
        "watchlist_stocks_count": 41,
        "like_count": 2078,
        "plus_tier": "year",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1149,
        "title": "StockTwits for iOS",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "conversation": {
        "parent_message_id": 255825164,
        "in_reply_to_message_id": null,
        "parent": true,
        "replies": 1
      },
      "links": [
        {
          "title": "Merck scraps Keytruda lung cancer trial adding Bristol Myers' Yervoy. What about the Opdivo combo?",
          "url": "https://www.fiercepharma.com/marketing/merck-scraps-keytruda-lung-cancer-trial-adding-bristol-myers-yervoy-what-about-opdivo",
          "shortened_url": "https://www.fiercepharma.com/marketing/merck-scraps-keytruda-lung-cancer-trial-adding-bristol-myers-yervoy-what-about-opdivo",
          "shortened_expanded_url": "fiercepharma.com/marketing/...",
          "description": "Merck's Keytruda is without doubt the king in previously untreated non-small cell lung cancer, but the company wanted to see whether adding another immuno-oncology agent from rival Bristol Myers Squibb would offer additional benefit. Turns out, doing that adds more harm and no good.",
          "image": "https://qtxasset.com/fiercepharma/1605024656/KeytrudaNew.jpg/KeytrudaNew.jpg?YMFKleVceiHUe8mdylP41_FPigdbVvV6",
          "created_at": "2020-11-11T04:29:59Z",
          "video_url": null,
          "source": {
            "name": "FiercePharma",
            "website": "https://www.fiercepharma.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255820313,
      "body": "$NVCR Republican Secretary of Defense under President Bill Clinton is outraged at the disrespect the Trump is showing for this Country. Trump is loosing the respect of well Respected Republicans! Something to know why Character matters. Cohen tonight is outraged at his parties lack of responsibility to do what is right for The Republic!!!",
      "created_at": "2020-11-11T03:42:44Z",
      "user": {
        "id": 1345391,
        "username": "jimbarb",
        "name": "James Borowski",
        "avatar_url": "http://avatars.stocktwits.com/images/default_avatar_thumb.jpg",
        "avatar_url_ssl": "https://s3.amazonaws.com/st-avatars/images/default_avatar_thumb.jpg",
        "join_date": "2018-01-02",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 14,
        "following": 0,
        "ideas": 1646,
        "watchlist_stocks_count": 1,
        "like_count": 4042,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "conversation": {
        "parent_message_id": 255820313,
        "in_reply_to_message_id": null,
        "parent": true,
        "replies": 1
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255805150,
      "body": "$NVCR over the next 10+ years what will give me better annual returns...$NVCR or spy/qqq/etc??",
      "created_at": "2020-11-11T01:45:31Z",
      "user": {
        "id": 1396153,
        "username": "NeuroRad",
        "name": "MG",
        "avatar_url": "https://avatars.stocktwits.com/production/1396153/thumb-1574739599.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1396153/thumb-1574739599.png",
        "join_date": "2018-02-02",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 27,
        "following": 3,
        "ideas": 1068,
        "watchlist_stocks_count": 54,
        "like_count": 1444,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2095,
        "title": "StockTwits For Android ",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "conversation": {
        "parent_message_id": 255805150,
        "in_reply_to_message_id": null,
        "parent": true,
        "replies": 1
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255794908,
      "body": "$NVCR Last night on FI. Amazing",
      "created_at": "2020-11-11T00:42:25Z",
      "user": {
        "id": 623810,
        "username": "tdorsey",
        "name": "Tom Dorsey",
        "avatar_url": "https://avatars.stocktwits.com/production/623810/thumb-1450378629.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/623810/thumb-1450378629.png",
        "join_date": "2015-10-29",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 233,
        "following": 37,
        "ideas": 9057,
        "watchlist_stocks_count": 15,
        "like_count": 2681,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2095,
        "title": "StockTwits For Android ",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "conversation": {
        "parent_message_id": 255794908,
        "in_reply_to_message_id": null,
        "parent": true,
        "replies": 9
      },
      "likes": {
        "total": 6,
        "user_ids": [
          707246,
          2133920,
          1396153,
          702677,
          1419594,
          1531906
        ]
      },
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_255794908.jpg",
          "large": "https://charts.stocktwits.com/production/large_255794908.jpg",
          "original": "https://charts.stocktwits.com/production/original_255794908.jpg",
          "url": "https://charts.stocktwits.com/production/original_255794908.jpg"
        },
        "sentiment": null
      }
    },
    {
      "id": 255789351,
      "body": "$NVCR If it breaks 113 is double digits in play???? 81?",
      "created_at": "2020-11-11T00:11:20Z",
      "user": {
        "id": 1345391,
        "username": "jimbarb",
        "name": "James Borowski",
        "avatar_url": "http://avatars.stocktwits.com/images/default_avatar_thumb.jpg",
        "avatar_url_ssl": "https://s3.amazonaws.com/st-avatars/images/default_avatar_thumb.jpg",
        "join_date": "2018-01-02",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 14,
        "following": 0,
        "ideas": 1642,
        "watchlist_stocks_count": 1,
        "like_count": 4042,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "conversation": {
        "parent_message_id": 255789351,
        "in_reply_to_message_id": null,
        "parent": true,
        "replies": 1
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255781400,
      "body": "$NVCR https://www.businesswire.com/news/home/20201110005358/en/Novocure-Announces-Agenda-for-Virtual-Research-and-Development-Day",
      "created_at": "2020-11-10T23:26:06Z",
      "user": {
        "id": 473304,
        "username": "Salayafarang",
        "name": "Salayafarang",
        "avatar_url": "https://avatars.stocktwits.com/production/473304/thumb-1489593853.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/473304/thumb-1489593853.png",
        "join_date": "2015-02-23",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 2,
        "following": 115,
        "ideas": 76,
        "watchlist_stocks_count": 76,
        "like_count": 176,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2095,
        "title": "StockTwits For Android ",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "conversation": {
        "parent_message_id": 255781400,
        "in_reply_to_message_id": null,
        "parent": true,
        "replies": 1
      },
      "links": [
        {
          "title": "Novocure Announces Agenda for Virtual Research and Development Day",
          "url": "https://www.businesswire.com/news/home/20201110005358/en/Novocure-Announces-Agenda-for-Virtual-Research-and-Development-Day",
          "shortened_url": "https://www.businesswire.com/news/home/20201110005358/en/Novocure-Announces-Agenda-for-Virtual-Research-and-Development-Day",
          "shortened_expanded_url": "businesswire.com/news/home/...",
          "description": "ST. HELIER, Jersey--()--Novocure (NASDAQ: NVCR) today announced the agenda for the company's virtual Research and Development Day for analysts and investors from 7:30 a.m. to 9:30 a.m. EST on Thursday, November 12, 2020. The event will review two decades of Tumor Treating Fields research on and introduce exciting new directions of ongoing research and development across the global scientific community.",
          "image": "https://mms.businesswire.com/media/20201110005358/en/721126/23/novocure_main%405x.jpg",
          "created_at": "2020-11-10T23:26:06Z",
          "video_url": null,
          "source": {
            "name": "Businesswire",
            "website": "https://www.businesswire.com"
          }
        }
      ],
      "likes": {
        "total": 1,
        "user_ids": [
          623810
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255737741,
      "body": "$NVCR enough of this growth to value rotation crap, I expect to see inflows tomorrow before R&amp;D day after today\u2019s move.",
      "created_at": "2020-11-10T20:54:38Z",
      "user": {
        "id": 707246,
        "username": "CCmoney7",
        "name": "C Marcus",
        "avatar_url": "http://avatars.stocktwits.com/images/default_avatar_thumb.jpg",
        "avatar_url_ssl": "https://s3.amazonaws.com/st-avatars/images/default_avatar_thumb.jpg",
        "join_date": "2016-03-15",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 17,
        "following": 68,
        "ideas": 4154,
        "watchlist_stocks_count": 89,
        "like_count": 1011,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1149,
        "title": "StockTwits for iOS",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 12802,
          "symbol": "NVCR",
          "title": "NovoCure",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 5419
        }
      ],
      "conversation": {
        "parent_message_id": 255737741,
        "in_reply_to_message_id": null,
        "parent": true,
        "replies": 1
      },
      "likes": {
        "total": 5,
        "user_ids": [
          1271837,
          1531906,
          2133920,
          1396153,
          1419594
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    }
  ]
}